Clinical studies recruiting near Ogden

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Advanced Research Institute · Kallyope Inc. · NCT07674654 A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid T
Phase 1 · START Mountain · Vividion Therapeutics, Inc. · NCT06804824 MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Ogden Regional Cancer Center · Agendia · NCT03053193 A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined
Phase 3 · Community Cancer Trials of Utah · Regeneron Pharmaceuticals · NCT06091865 A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Phase 2 · Investigational Site Number: 8400016 · Sanofi · NCT06958536 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · McKay-Dee Hospital Center · NRG Oncology · NCT05946213 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · McKay-Dee Hospital Center · NRG Oncology · NCT05174169 Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Phase 3 · Rio Clinical Trials - Canyon View- Site Number : 8400031 · Sanofi · NCT07348692 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Community Cancer Trials of Utah - South Ogden /ID# 262829 · AbbVie · NCT04928846 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Advanced Research Institute /ID# 259821 · AbbVie · NCT06345339 Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · McKay-Dee Hospital Center · NRG Oncology · NCT03180268 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · Rio Clinical Trials - Corporate Office · Crystalys Therapeutics · NCT07089888 OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Phase 3 · Clinical Trial Site · Olema Pharmaceuticals, Inc. · NCT06016738 A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Phase 3 · Advanced Research Institute - Ogden · Ardelyx · NCT07382167 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · McKay-Dee Hospital Center · NRG Oncology · NCT04852887 Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Phase 4 · Advanced Research Institute Ogden · Mayo Clinic · NCT06972056 A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-108
Phase 3 · Community Cancer Trials of Utah ( Site 0086) · Merck Sharp & Dohme LLC · NCT06997497 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · Ogden Clinic - Canyon View · Eli Lilly and Company · NCT07282600 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in
Phase 3 · Advanced Research Institute - Odgen (ARI - Ogden)- Site Numb · Sanofi · NCT06241118 A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Mult
Phase N/A · TG Therapeutics Investigational Trial Site · TG Therapeutics, Inc. · NCT06433752 S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic
NA · McKay-Dee Hospital Center · SWOG Cancer Research Network · NCT03723928 LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Phase 2 · Care Access - Ogden · Eli Lilly and Company · NCT07186101 Adaptation and Pilot Implementation of ePNa Clinical Decision Support for Utah Urgent Care Clinics
NA · North Ogden Instacare · Intermountain Health Care, Inc. · NCT04606849 Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed
Phase 3 · Community Cancer Trials of Utah-Investigational Site Number: · Sanofi · NCT07007962 A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participant
Phase 3 · AbbVie · NCT05889182 Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Phase 3 · McKay-Dee Hospital Center · ECOG-ACRIN Cancer Research Group · NCT03937635 Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harbor
Phase 3 · Community Cancer Trials of Utah · Boehringer Ingelheim · NCT07195695 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · SWOG Cancer Research Network · NCT03851445 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · SWOG Cancer Research Network · NCT05642572 A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Phase 2 · Investigational Site Number: 8400007 · Sanofi · NCT06975722

Look up another city

Look up another condition